- Cite This Article as
- Corresponding Author
Background: Prostate cancer is one of the most common malignancies diagnosed in men & is the most common cancer found in men older than 60 years. One third of all men older than 50 years have a latent form of prostate cancer that may progress to life threatening Prostate cancer. In this study all the precancerous lesions were more common in the higher age groups (60-69 and 70-79 years). Material And Methods: The present study has been performed on 100 patients in the department of Surgery , Eras Lucknow medical college and hospital. The age of the patients varied from 40-80 years. Maximum proportion of patients (34%) were aged between 60-69 yrs followed by 70-79 yrs (30%). There were 12% patients in age grp 40-49 yrs and 24% were in the age group of 50-59 years. Thus it was seen that the complaints of lower urinary tract system or prostatic disease were common in higher age group. Results: In this study all the precancerous lesions were more common in the higher age groups (60-69 and 70-79 years). However , no statistically significant association between type of lesion and age could be established in this study (p=0.267). Studying the histopathology only peripheral and central zones were seen to be involved. Peripheral zone was involved in 4/5 (80%) cases while central zone was involved in 1/5 (20%) cases Overall, in the present study, PIN was found to be an efficacious marker for prognosis of prostate carcinoma.
- Harvard Prostate Knowledge.
- McNeal, JE. Origin and development of carcinoma in prostate. Cancer 1969;23:24.
- Drago, JR, Mastofi, FK, Lee, F. Introductory remarks and workshop summary. Urology 1992;39:2.
- Bostwick DG, Amin MB, Dundore P, Marsh W, Schultz DS. Architectural pattern of high grade prostatic intraepithelial neoplasia. Hum Pathol. Mar 1993;24(3):298-310.
- Bostwik DG. Prostatic intraepithelial neoplasia. Current Urology reports 2000;1(1):65-70.
- Bostwik DG, Neumann R, Qian J, Cheng L. Reversibility of Prostatic intraepithelial Neoplasia. Implications for chemoprevention. Eur Urol 1999;35:492-495.
- Shahrokh F Shariat, Claus G Roehrbom. Using Biopsy to Detect Prostate Cancer. Urology2008;10(4):262-280.
- Ximing J Yang. Precancerous lesions of prostate:Pathology and clinical implications. Uptodate Literture review July 2017.
- Stanley A Brosman.Precancerous lesion of the Prostate.Medscape Feb 2017.
- Sunny L, Yeole BB, Kurkure AP, Hakama M, Shiri R,Mathews S, Shastri NG, Advani SH. Cumulative risk and trends in prostate cancer incidence in Mumbai, India. Asian Pac J Cancer Prev. 2004 Oct-Dec;5(4):401-5.
- Wills M, Hamper U, Partin A, Epstein J. Incidence of high grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens. Urology 1997;49(3):367-373.
- Orozco R, O Dowd G, Kunnel B, Miller MC,Veltri RW. Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States. Urology. Feb 1998;51(2):186-95.
- Novis DA, Zarbo RJ, Valenstein PA. Diagnostic uncertainty expressed in prostate needle biopsies. A college of American Pathologists Q-probes Study of 15,753 prostate needle biopsies in 332 institutions. Arch Pathol Lab Med. Aug 1999;123(8):687-92.
[S. S. Haider, Tahsin Munsif and Vineeta Tewari. (2018); PRECANCEROUS LESIONS OF PROSTATE A CLINICO-PATHOLOGICAL STUDY. Int. J. of Adv. Res. 6 (1). 1-5] (ISSN 2320-5407). www.journalijar.com
Assistant Professor, Anatomy, Eras Lucknow Medical College & Hospital
Article DOI: 10.21474/IJAR01/6176 DOI URL: http://dx.doi.org/10.21474/IJAR01/6176
Share this article
This work is licensed under a Creative Commons Attribution 4.0 International License.